amiodarone has been researched along with Actinic Reticuloid Syndrome in 56 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For decades, the photodistributed blue-gray skin hyperpigmentation observed after amiodarone therapy was presumably attributed to dermal lipofuscinosis." | 7.74 | Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin. ( Alvarez, F; Ammoury, A; Bazex, J; Chouini-Lalanne, N; Lamant, L; Launay, F; Marguery, MC; Michaud, S; Paul, C; Prost-Squarcioni, C, 2008) |
| "A dose-dependent cutaneous leukocytoclastic vasculitis developed in a 34 year old man who was given amiodarone for supraventricular tachycardias resistant to other drugs." | 7.67 | Amiodarone-induced vasculitis and polyserositis. ( Bircher, J; Stäubli, M; Zimmermann, A, 1985) |
| "Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone." | 7.66 | Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. ( Girotti, LA; Kaski, JC; Messuti, H; Rosenbaum, MB; Rutitzky, B, 1981) |
| "Pirfenidone is an antifibrotic agent potentially effective for IPF therapy, and preclinical and available clinical data support its use in IPF." | 6.43 | Pirfenidone for the treatment of idiopathic pulmonary fibrosis. ( Antoniu, SA, 2006) |
| "Twenty patients with photodermatoses [actinic prurigo (n = 6), hydroa vacciniforme (n = 4), idiopathic solar urticaria (n = 1), amiodarone-induced photosensitivity (n = 1) and a range of cutaneous porphyrias (n = 8)] were treated with a 'hardening' course of narrow-band ultraviolet B (TL-01) phototherapy in springtime." | 5.08 | Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. ( Collins, P; Ferguson, J, 1995) |
| "A 45-year-old man had severe blue-gray cutaneous discoloration during amiodarone therapy for atrial fibrillation." | 4.78 | Reversibility of blue-gray cutaneous discoloration from amiodarone. ( Blackshear, JL; Randle, HW, 1991) |
| "For decades, the photodistributed blue-gray skin hyperpigmentation observed after amiodarone therapy was presumably attributed to dermal lipofuscinosis." | 3.74 | Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin. ( Alvarez, F; Ammoury, A; Bazex, J; Chouini-Lalanne, N; Lamant, L; Launay, F; Marguery, MC; Michaud, S; Paul, C; Prost-Squarcioni, C, 2008) |
| "In the adult, Amiodarone is a very effective drug in the treatment of ventricular and supraventricular arrhythmias." | 3.67 | [Amiodarone therapy in childhood: efficacy and side effects]. ( Austoni, P; Danzi, GB; Fancini, P; Figini, A; Mascarello, M; Vignati, G, 1985) |
| "A dose-dependent cutaneous leukocytoclastic vasculitis developed in a 34 year old man who was given amiodarone for supraventricular tachycardias resistant to other drugs." | 3.67 | Amiodarone-induced vasculitis and polyserositis. ( Bircher, J; Stäubli, M; Zimmermann, A, 1985) |
| "Twenty-three patients with sustained, recurrent, symptomatic ventricular tachycardia were treated with oral amiodarone." | 3.66 | Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. ( Girotti, LA; Kaski, JC; Messuti, H; Rosenbaum, MB; Rutitzky, B, 1981) |
| "Pirfenidone is an antifibrotic agent potentially effective for IPF therapy, and preclinical and available clinical data support its use in IPF." | 2.43 | Pirfenidone for the treatment of idiopathic pulmonary fibrosis. ( Antoniu, SA, 2006) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| "Amiodarone is a antiarrhythmic drug with many side-effects which include also the induction of photosensitivity and the development of greyish-blue pigmentations on the skin exposed to light." | 1.29 | Skin side-effects of amiodarone therapy. ( Ettler, K; Gregor, J; Nozi cková, M; Pidrman, V; Subrtová, D, 1993) |
| "Hypothyroidism was diagnosed in 11 (in 8 by the finding of elevated TSH)." | 1.28 | [Complications of low-dose amiodarone]. ( Feigl, D; Gilad, R; Katz, E, 1991) |
| "Amiodarone is an iodinated cardiac antiarrhythmic drug that causes a slate- gray discoloration of sun-exposed skin." | 1.28 | [Amiodarone-induced pigmentation. A histological, ultrastructural study and review of the literature]. ( Bollati, A; Borroni, G; Brazzelli, V; Dal Tio, R; Rabbiosi, G; Riva, R, 1990) |
| "Amiodarone is a powerful anti-arrhythmic drug." | 1.27 | Noncardiac side-effects of long-term oral amiodarone in the elderly. ( Bailey, RJ; Hyatt, RH; Martin, A; Sinha, B; Vallon, A, 1988) |
| "An unusual case of recurrence of amiodarone pulmonary toxicity is described." | 1.27 | [Recurrent alveolitis caused by amiodarone]. ( Ciani, F; Padrini, R; Pandullo, C; Pivotti, F; Scardi, S, 1986) |
| "Amiodarone, used in the treatment of cardiac arrhythmia, may lead to severe discolouration of sun-exposed skin." | 1.27 | Morphological changes in peripheral blood cells and skin in amiodarone-treated patients. ( Konrad, K; Rappersberger, K; Weber, H; Wieser, E; Wolff, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (64.29) | 18.7374 |
| 1990's | 10 (17.86) | 18.2507 |
| 2000's | 10 (17.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maoz, KB | 1 |
| Dvash, S | 1 |
| Brenner, S | 2 |
| Hall, MA | 1 |
| Annas, A | 1 |
| Nyman, K | 1 |
| Talme, T | 1 |
| Emtestam, L | 1 |
| Yones, SS | 1 |
| O'Donoghue, NB | 1 |
| Palmer, RA | 1 |
| Menagé, Hdu P | 1 |
| Hawk, JL | 1 |
| Antoniu, SA | 1 |
| Ammoury, A | 1 |
| Michaud, S | 1 |
| Paul, C | 1 |
| Prost-Squarcioni, C | 1 |
| Alvarez, F | 1 |
| Lamant, L | 1 |
| Launay, F | 1 |
| Bazex, J | 1 |
| Chouini-Lalanne, N | 1 |
| Marguery, MC | 1 |
| Kaufmann, G | 1 |
| Guerciolini, R | 1 |
| Del Favero, A | 1 |
| Cannistraro, S | 1 |
| Ferguson, J | 4 |
| de Vane, PJ | 1 |
| Wirth, M | 1 |
| Chalmers, RJ | 2 |
| Muston, HL | 2 |
| Srinivas, V | 1 |
| Bennett, DH | 1 |
| Waxman, HL | 1 |
| Groh, WC | 1 |
| Marchlinski, FE | 1 |
| Buxton, AE | 1 |
| Sadowski, LM | 1 |
| Horowitz, LN | 1 |
| Josephson, ME | 1 |
| Kastor, JA | 1 |
| Harris, L | 3 |
| McKenna, WJ | 5 |
| Rowland, E | 4 |
| Holt, DW | 4 |
| Storey, GC | 2 |
| Krikler, DM | 3 |
| Zipes, DP | 1 |
| Prystowsky, EN | 1 |
| Heger, JJ | 1 |
| Walter, JF | 1 |
| Bradner, H | 1 |
| Curtis, GP | 1 |
| Weiss, SR | 1 |
| Lim, HW | 1 |
| Curtis, G | 1 |
| Zachary, CB | 1 |
| Slater, DN | 1 |
| MacDonald, DM | 1 |
| Diffey, BL | 1 |
| Quintanilla, E | 1 |
| Tuñón, T | 1 |
| Fernández-Berridi, D | 1 |
| Pardo-Mindán, FJ | 1 |
| Kaski, JC | 1 |
| Girotti, LA | 1 |
| Messuti, H | 1 |
| Rutitzky, B | 1 |
| Rosenbaum, MB | 1 |
| Korting, HC | 1 |
| Kolz, R | 1 |
| Schmoeckel, C | 1 |
| Balda, BR | 1 |
| Collins, P | 1 |
| Monk, BE | 1 |
| Shukla, R | 1 |
| Jowett, NI | 1 |
| Thompson, DR | 1 |
| Pohl, JE | 1 |
| Ettler, K | 1 |
| Gregor, J | 1 |
| Pidrman, V | 1 |
| Subrtová, D | 1 |
| Nozi cková, M | 1 |
| Ammann, R | 1 |
| Braathen, LR | 1 |
| Villain, E | 1 |
| Rogers, KC | 1 |
| Wolfe, DA | 1 |
| Haas, N | 1 |
| Schadendorf, D | 1 |
| Hermes, B | 1 |
| Henz, BM | 1 |
| Wilkinson, CM | 1 |
| Weidner, GJ | 1 |
| Paulino, AC | 1 |
| Wohlrab, J | 1 |
| Fischer, M | 1 |
| Stoldt, G | 1 |
| Marsch, WC | 1 |
| Feigl, D | 1 |
| Gilad, R | 1 |
| Katz, E | 1 |
| Blackshear, JL | 1 |
| Randle, HW | 1 |
| Brazzelli, V | 1 |
| Borroni, G | 1 |
| Dal Tio, R | 1 |
| Riva, R | 1 |
| Bollati, A | 1 |
| Rabbiosi, G | 1 |
| Monk, B | 1 |
| Roupe, G | 1 |
| Larkö, O | 1 |
| Olsson, SB | 1 |
| Rappersberger, K | 2 |
| Hönigsmann, H | 1 |
| Ortel, B | 1 |
| Tanew, A | 1 |
| Konrad, K | 2 |
| Wolff, K | 2 |
| Willems, AR | 1 |
| Schöttelndreiër, MA | 1 |
| Vignati, G | 1 |
| Danzi, GB | 1 |
| Austoni, P | 1 |
| Fancini, P | 1 |
| Mascarello, M | 1 |
| Figini, A | 1 |
| Waitzer, S | 1 |
| Butany, J | 1 |
| From, L | 1 |
| Hanna, W | 1 |
| Ramsay, C | 1 |
| Downar, E | 1 |
| Keeton, BR | 1 |
| Bucknall, CA | 1 |
| Curry, PV | 1 |
| Joseph, MC | 1 |
| Sutherland, GR | 1 |
| Mulrow, JP | 2 |
| Beukema, WP | 1 |
| Graboys, TB | 1 |
| Hyatt, RH | 1 |
| Sinha, B | 1 |
| Vallon, A | 1 |
| Bailey, RJ | 1 |
| Martin, A | 1 |
| Toback, AC | 1 |
| Anders, JE | 1 |
| Ljunggren, B | 1 |
| Bjellerup, M | 1 |
| Scardi, S | 1 |
| Ciani, F | 1 |
| Pandullo, C | 1 |
| Padrini, R | 1 |
| Pivotti, F | 1 |
| Boyle, J | 1 |
| Török, L | 1 |
| Szekeres, L | 1 |
| Lakatos, A | 1 |
| Szücs, M | 1 |
| Mulrow, CD | 1 |
| Wieser, E | 1 |
| Weber, H | 1 |
| Stäubli, M | 1 |
| Zimmermann, A | 1 |
| Bircher, J | 1 |
| Vila Serra, MD | 1 |
| Valdés Martínez, V | 1 |
| Marcos Bruguera, JM | 1 |
| Badal Alter, JM | 1 |
| Addo, HA | 1 |
| Jones, S | 1 |
| Johnson, BE | 1 |
| Frain-Bell, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for amiodarone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Cell | 2006 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
Reversibility of blue-gray cutaneous discoloration from amiodarone.
Topics: Amiodarone; Atrial Fibrillation; Follow-Up Studies; Humans; Male; Middle Aged; Photosensitivity Diso | 1991 |
[Amiodarone and its side effects].
Topics: Amiodarone; Chemical and Drug Induced Liver Injury; Corneal Diseases; Humans; Lung Diseases; Periphe | 1988 |
Systemic drug photosensitivity.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents; Benzodiazepines; Benzofurans; Griseofulvin; Humans; N | 1986 |
2 trials available for amiodarone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses.
Topics: Adolescent; Adult; Amiodarone; Child; Drug Hypersensitivity; Female; Humans; Hydroa Vacciniforme; Ma | 1995 |
Pyridoxine and amiodarone-induced photosensitivity.
Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Double-Blind Method; Female; Humans; | 1985 |
48 other studies available for amiodarone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Drug-induced photosensitivity.
Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2009 |
Amiodarone-induced skin pigmentation and multiple basal-cell carcinomas.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Basal Cell; Color; Dermis; Humans; Male; Micros | 2009 |
Basalioma after amiodarone therapy-not only in Britain.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Basal Cell; Female; Humans; Middle Aged; Photosensiti | 2004 |
Persistent severe amiodarone-induced photosensitivity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Facial Dermatoses; Female; Humans; Hyperpigmentation; Phot | 2005 |
Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biopsy, Needle; Chromatography, High Pressure Liquid; Facial Der | 2008 |
Pyridoxine against amiodarone-induced photosensitivity.
Topics: Aged; Amiodarone; Benzofurans; Female; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrido | 1984 |
Amiodarone-induced photosensitivity and pyridoxine.
Topics: Amiodarone; Benzofurans; Humans; Melanins; Photosensitivity Disorders; Pyridoxine | 1984 |
Prevention of amiodarone-induced photosensitivity.
Topics: Amiodarone; Benzofurans; Humans; Photosensitivity Disorders; Titanium; Zinc | 1984 |
High incidence of amiodarone-induced photosensitivity in North-west England.
Topics: Amiodarone; Benzofurans; Drug Eruptions; England; Female; Humans; Male; Photosensitivity Disorders; | 1982 |
Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Chemical and Drug Indu | 1982 |
Side effects of long-term amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1983 |
Amiodarone photosensitivity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Erythema; Humans; Male; Photosensitivity Disord | 1984 |
Slate-gray pigmentation of sun-exposed skin induced by amiodarone.
Topics: Amiodarone; Benzofurans; Humans; Male; Middle Aged; Myocardial Infarction; Photosensitivity Disorder | 1984 |
Side effects and possible contraindications of amiodarone use.
Topics: Aged; Alanine Transaminase; Amiodarone; Aspartate Aminotransferases; Benzofurans; Corneal Diseases; | 1983 |
The pathogenesis of amiodarone-induced pigmentation and photosensitivity.
Topics: Adult; Amiodarone; Benzofurans; Chromatography, High Pressure Liquid; Electron Probe Microanalysis; | 1984 |
Photobiology of amiodarone: preliminary in vitro and in vivo studies.
Topics: Adult; Amiodarone; Benzofurans; Humans; Middle Aged; Photochemistry; Photosensitivity Disorders; Spe | 1984 |
[Cutaneous pigmentation caused by amiodarone. Optical and ultrastructural study].
Topics: Adult; Aged; Amiodarone; Benzofurans; Cytoplasmic Granules; Female; Humans; Male; Middle Aged; Photo | 1982 |
Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Corneal Diseases; Humans; Long-Term Ca | 1981 |
[Amiodarone pigmentation. A rare, but typical drug side-effect].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Humans; Male | 1981 |
Basal cell carcinoma following amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Basal Cell; Humans; Male; Photosensitivity Diso | 1995 |
Side effects with amiodarone therapy.
Topics: Aged; Amiodarone; Drug Administration Schedule; Drug Eruptions; Female; Humans; Male; Middle Aged; N | 1994 |
Skin side-effects of amiodarone therapy.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Eruptions; Humans; Hyperpig | 1993 |
[Amiodarone pigmentation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Eruptions; Female; Humans; Lipofuscin; Long-Term Care; Midd | 1996 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
Amiodarone-induced blue-gray syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Photosensitivity Disorders; Skin Pigmentatio | 2000 |
Hypomelanosis due to block of melanosomal maturation in amiodarone-induced hyperpigmentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biopsy; Facial Dermatoses; Humans; Hyperpigmentation; Male; Mela | 2001 |
Amiodarone and radiation therapy sequelae.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Photosensitivity Disord | 2001 |
[52-year old patient with skin discoloration].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Melanosis; Middle Aged; Photosensitivity Disorders | 2001 |
[Complications of low-dose amiodarone].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Photosensitivity Disorders | 1991 |
[Amiodarone-induced pigmentation. A histological, ultrastructural study and review of the literature].
Topics: Aged; Amiodarone; Biopsy; Facial Dermatoses; Female; Humans; Male; Middle Aged; Photosensitivity Dis | 1990 |
Amiodarone-induced photosensitivity and basal-cell carcinoma.
Topics: Aged; Amiodarone; Carcinoma, Basal Cell; Humans; Male; Middle Aged; Photosensitivity Disorders; Skin | 1990 |
Amiodarone photoreactions.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Photosensitivity Disorders; Skin | 1987 |
Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery.
Topics: Amiodarone; Face; Humans; Microscopy, Electron; Photosensitivity Disorders; Pigmentation Disorders; | 1989 |
[Amiodarone therapy in childhood: efficacy and side effects].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomegaly; Child | 1985 |
Cutaneous ultrastructural changes and photosensitivity associated with amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Complement C3; Female; Humans; Inclusion Bodies; Lipofuscin; Male; Middle A | 1987 |
Use of amiodarone in childhood.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Preschool; Corneal Diseases | 1986 |
Amiodarone dose titration: a method to minimise side effects during long term therapy.
Topics: Amiodarone; Benzofurans; Cardiomyopathy, Hypertrophic; Humans; Long-Term Care; Photosensitivity Diso | 1986 |
Amiodarone: a study of cutaneous photosensitivity.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Child; Drug Hypersensitivity; Female; Humans; Male | 1986 |
Spontaneous disappearance of blue-gray facial pigmentation during amiodarone therapy (out of the blue).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Humans; Male; Photosensiti | 1988 |
Noncardiac side-effects of long-term oral amiodarone in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Aspartate Aminotran | 1988 |
Phototoxicity from systemic agents.
Topics: Amiodarone; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chlorpromazine; Diuretics; Furocoumarin | 1986 |
[Recurrent alveolitis caused by amiodarone].
Topics: Amiodarone; Benzofurans; Eye Diseases; Female; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; | 1986 |
Amiodarone-induced cutaneous photosensitivity.
Topics: Amiodarone; Benzofurans; Humans; Male; Middle Aged; Photosensitivity Disorders; PUVA Therapy | 1986 |
[Amiodarone-induced hyperpigmentation].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Photosen | 1986 |
Morphological changes in peripheral blood cells and skin in amiodarone-treated patients.
Topics: Amiodarone; Benzofurans; Humans; Leukocytes; Lysosomes; Microscopy, Electron; Photosensitivity Disor | 1986 |
Amiodarone-induced vasculitis and polyserositis.
Topics: Adult; Amiodarone; Benzofurans; Humans; Male; Necrosis; Photosensitivity Disorders; Serositis; Tachy | 1985 |
[Intense photodermatosis due to amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Female; Humans; Photosensitivity Disorders | 1985 |
A study of cutaneous photosensitivity induced by amiodarone.
Topics: Adult; Aged; Amiodarone; Benzofurans; Cells, Cultured; Child; Erythema; Erythrocytes; Female; Humans | 1985 |